Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy

Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy

Globally, human immunodeficiency virus type 1 (HIV-1) infection is a major health burden for which successful therapeutic options are still being investigated. Challenges facing current drugs that are part of the established life-long antiretroviral therapy (ART) include toxicity, development of dru...

Full description

Bibliographic Details
Main Authors:	Hager Mohamed, Theodore Gurrola, Rachel Berman, Mackenzie Collins, Ilker K. Sariyer, Michael R. Nonnemacher, Brian Wigdahl
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-01-01
Series:	Frontiers in Immunology
Subjects:	antiretroviral drugs CCR5Δ32 CCR5 monoclonal antibodies CCR5 small molecule inhibitors HIV-1 drug resistance zinc finger nucleases
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.816515/full

Similar Items

Evaluation of CCR5Δ32 Polymorphism in Patients with Systemic Lupus Erythematosus and Healthy Individuals
by: Zahra Heydarifard, et al.
Published: (2018-03-01)

Cysteine-cysteine chemokine receptor 5 (CCR5) profile of HIV-infected subjects attending University of Calabar Teaching Hospital, Calabar, Southern Nigeria
by: Ekerette Friday Ekere, et al.
Published: (2020-01-01)

The frequency of allele CCR5Δ32 in a Serbian population
by: Đorđević Valentina, et al.
Published: (2013-01-01)

Detection of CCR5Δ32 Mutant Alleles in Heterogeneous Cell Mixtures Using Droplet Digital PCR
by: Alyona Sorokina, et al.
Published: (2022-02-01)

Editorial: CCR5: A receptor at the center stage in infection
by: Joel Henrique Ellwanger, et al.
Published: (2022-10-01)

The Abrogation of Phosphorylation Plays a Relevant Role in the CCR5 Signalosome Formation with Natural Antibodies to CCR5
by: Assunta Venuti, et al.
Published: (2017-12-01)

Distribution of the CCR5delta32 allele (gene variant CCR5) in Rondônia, Western Amazonian region, Brazil
by: Josileide Duarte de Farias, et al.
Published: (2012-01-01)

The frequency of CCR5 promoter polymorphisms and CCR5 32 mutation in Iranian populations
by: Mohammad Zare-Bidaki, et al.
Published: (2015-04-01)

Pushing it back. Dating the CCR5–32 bp deletion to the Mesolithic in Sweden and its implications for the Meso\Neo transition
by: Kerstin Lidén, et al.
Published: (2006-12-01)

CCR3, CCR4, CCR5, and CXCR3 expression in peripheral blood CD4+ lymphocytes in gastric cancer patients
by: Alireza Andalib, et al.
Published: (2013-01-01)

Evaluation of prevalence of  32 mutation in CCR5 gene in breast cancer patients in Rafsanjan city
by: Mohammad Kazemi Arababadi, et al.
Published: (2009-01-01)

The CCL5/CCR5 Axis in Cancer Progression
by: Donatella Aldinucci, et al.
Published: (2020-07-01)

Cenicriviroc, a dual CCR2 and CCR5 antagonist leads to a reduction in plasma fibrotic biomarkers in persons living with HIV on antiretroviral therapy
by: S. Bowler, et al.
Published: (2019-09-01)

The effect of combined polymorphisms in chemokines and chemokine receptors on the clinical course of HIV-1 infection in a Brazilian population
by: Valdimara Corrêa Vieira, et al.
Published: (2011-06-01)

Expression of the Chemokine Receptor CCR1 in Burkitt Lymphoma Cell Lines Is Linked to the CD10-Negative Cell Phenotype and Co-Expression of the EBV Latent Genes EBNA2, LMP1, and LMP2
by: Laura Zvejniece, et al.
Published: (2022-03-01)

CCR4 and CCR5 Involvement in Monocyte-Derived Macrophage Migration in Neuroinflammation
by: Jong Youl Kim, et al.
Published: (2022-05-01)

Genetic diversity and prevalence of CCR2-CCR5 gene polymorphisms in the Omani population
by: Samira H. Al-Mahruqi, et al.
Published: (2014-01-01)

Δ<i>ccr5</i> Genotype Is Associated with Mild Form of Nephropathia Epidemica
by: Konstantin Kletenkov, et al.
Published: (2019-07-01)

CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape
by: Gero Hütter, et al.
Published: (2015-07-01)

Frequency of polymorphisms of genes coding for HIV-1 co-receptors CCR5 and CCR2 in a Brazilian population
by: Munerato Patrícia, et al.
Published: (2003-01-01)

Frequency of polymorphisms of genes coding for HIV-1 co-receptors CCR5 and CCR2 in a Brazilian population
by: Patrícia Munerato, et al.

Investigating the association of chemokine receptor 5 (CCR5) polymorphism with cervical cancer in human papillomavirus (HPV) positive patients = Investigação da associação do polimorfismo do receptor de quimiocinas CCR5 com câncer cervical em pacientes HPV positivos
by: Patrícia Sayuri Suzuki, et al.
Published: (2008-10-01)

Antagonist of chemokine receptors CCR1 and CCR3
by: Ammit Alaina, et al.
Published: (2000-11-01)

CCR5: From Natural Resistance to a New Anti-HIV Strategy
by: Lucia Lopalco
Published: (2010-02-01)

Maraviroc – a CCR5 antagonist for the treatment of HIV-1 infection
by: Elna eVan Der Ryst
Published: (2015-06-01)

The Latitude Wise Prevalence of the CCR5-Δ32-HIV Resistance Allele in India
by: Bhatnagar I, et al.
Published: (2009-01-01)

Alterations in chemokine receptor CCR5 activity influence tumor cell biology in human cholangiocarcinoma cell lines
by: Jiaqi Yang, et al.
Published: (2021-03-01)

CCR5-Δ32 biology, gene editing, and warnings for the future of CRISPR-Cas9 as a human and humane gene editing tool
by: MengMeng Xu
Published: (2020-03-01)

Autopsy Study Defines Composition and Dynamics of the HIV-1 Reservoir after Allogeneic Hematopoietic Stem Cell Transplantation with CCR5Δ32/Δ32 Donor Cells
by: Laura E. P. Huyveneers, et al.
Published: (2022-09-01)

Transcriptional down-regulation of ccr5 in a subset of HIV+ controllers and their family members
by: Elena Gonzalo-Gil, et al.
Published: (2019-04-01)

Pleiotropy Complicates Human Gene Editing: CCR5Δ32 and Beyond
by: Ting Li, et al.
Published: (2019-07-01)

Systematic Assessment of Chemokine Signaling at Chemokine Receptors CCR4, CCR7 and CCR10
by: Herman D. Lim, et al.
Published: (2021-04-01)

High frequency of the CCR5delta32 variant among individuals from an admixed Brazilian population with sickle cell anemia
by: J.A.B. Chies, et al.
Published: (2003-01-01)

The Lack of the Association of the CCR5 Genotype with the Clinical Presentation and Frequency of Tick-Borne Encephalitis in the Polish Population
by: Sambor Grygorczuk, et al.
Published: (2022-03-01)

The association between diabetic nephropathy and polymorphisms in PPARγ Pro12Ala and CCR5δ 32 genes in type 2 diabetes
by: Asmaa I. Ahmed, et al.
Published: (2013-01-01)

CCL5/CCR5 axis in human diseases and related treatments
by: Zhen Zeng, et al.
Published: (2022-01-01)

The Dual Role of CCR5 in the Course of Influenza Infection: Exploring Treatment Opportunities
by: Maximiliano Ruben Ferrero, et al.
Published: (2022-01-01)

Use of maraviroc, the first CCR5 receptor antagonist, in HIV treatment regimens
by: A V Kravchenko
Published: (2013-11-01)

Factors Influencing Immune Restoration in People Living with HIV/AIDS
by: Bogusz Jan Aksak-Wąs, et al.
Published: (2022-03-01)

The hypothesis of non-African origin of human immunodeficiency virus type 1
by: V. P. Sergiev
Published: (2014-09-01)